Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
about
Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer CellsAssociation of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysisEffect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational StudyThe Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.
P2860
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@ast
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@en
type
label
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@ast
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@en
prefLabel
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@ast
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@en
P2093
P2860
P1476
Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.
@en
P2093
Donghui Li
James L Abbruzzese
Manal M Hassan
Ping Chang
Saiching J Yeung
Yixiang Mao
P2860
P304
P577
2015-09-15T00:00:00Z